Search
for
Sort by
Research 30 of 1000+
- The association of medications and supplements with human male reproductive health: a systematic review
- Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome
- PSAT097 Patient Preference Research: Preferred Adjunctive Medication Attributes of Adult Patients with Classic Congenital Adrenal Hyperplasia
- A Literature Review of the Effects of PCOS on Cardiovascular Health
- A Retrospective Study on the Safety of Systemic Minoxidil for Hair Loss in the Older Population
- An Overview of Harmful Effects of Polycystic Ovary Syndrome
- Cross-Sectional Study Of The Association Between Skin Tags And Vascular Risk Factors In A Bariatric Clinic-Based Cohort Of Irish Adults With Morbid Obesity
- Endocrinology of Transgender Medicine
- Resistance to the Insulin and Elevated Level of Androgen: A Major Cause of Polycystic Ovary Syndrome
- Cross-sectional study of the association between skin tags and vascular risk factors in a bariatric clinic-based cohort of Irish adults with morbid obesity
- Medical and Surgical Hair Restoration
- Androgenetic Alopecia From A to Z
- Cardiovascular profile of pharmacological agents used for the management of polycystic ovary syndrome
- Repurposing of approved cardiovascular drugs
- Adverse Dermatologic Effects of Cardiovascular Drug Therapy: Part III
- Drugs and Hair Loss
- A study to assess the co-morbidities and complications of polycystic ovarian syndrome
- NEW PROPRIETARY BRANDS: Gabapentin
- Metabolic Aspects of Polycystic Ovary Syndrome
- No Increased Cardiovascular Hazard with Oral 5-Alpha-Reductase Inhibitors in Treatment of Androgenetic Alopecia: A TriNetX Retrospective Cohort Study
- Polycystic Ovary Syndrome: A Complex Interplay of Hormones and Metabolism
- 61131 Impact of Low-Dose Oral Minoxidil on Blood Pressure in Androgenetic Alopecia Patients Concomitantly Taking Antihypertensive Medications: A Multi-Center Cohort Study
- Medication Clusters at Hospital Discharge and Risk of Adverse Drug Events at 30-days Post-Discharge: A Population-based Cohort Study of Older Adults
- Diagnosis dan Tata Laksana Graves’ Disease
- Association of common medication with prostate-specific antigen level in 45-year-old German men: Results of the PROBASE trial
- THE IMPACT OF HOMOCYSTEINE IN LUPUS ERYTHEMATOSUS: A LINK OF INFLAMMATION, SKIN AND CARDIOVASCULAR RISK
- Ovarian Hypertension: Polycystic Ovary Syndrome
- Baricitinib Safety for Events of Special Interest in Populations at Risk: Analysis from Randomised Trial Data Across Rheumatologic and Dermatologic Indications
- NEW PROPRIETARY BRANDS: Cephalexin
- NEW FORMULATIONS: Sodium cromoglycate